Octave

Market position

Octave describes itself as an innovator in outcomes-focused behavioral health care and reported at its 2023 Series C that its value-based care model produced first-of-its-kind partnerships with major national payers. It positions in-network, insurance-covered therapy against the US market average therapy cost of $100–$250 per session cited on its own site. No independent market-share data appears in the sources.

Octave emphasizes in-network insurance coverage that lowers average out-of-pocket cost to roughly $28 per session, a curated and continuously vetted therapist network with specialty teams and 40+ languages, short time-to-first-appointment, routine outcome measurement, and administrative support (payer contracting, billing, scheduling) that removes insurance overhead from clinicians. It contrasts its personalized, evidence-based care plans with "one-size-fits-all" approaches.

Technology

The consumer product includes a matching flow that captures needs, state, insurance, and up to three support areas to generate therapist matches; a free insurance cost-estimation tool; online scheduling; live chat support; and telehealth session delivery. Octave applies routine measurement of client symptom progress to inform care plans and reports outcomes at the population level. The company said 2023 funding would support new technology products for payer and provider partners. Built In lists internal tools including Linear (project management), Airtable, and Iterable (email).

Go-to-market

Direct-to-consumer acquisition through its website, with an online intake questionnaire, therapist browsing, insurance cost estimator, live chat support, and a care navigation team that guides matching. Distribution is amplified by in-network relationships with insurers such as Aetna and Cigna, which place Octave in payer networks; client testimonials cite referrals to friends and coworkers. Provider-side recruiting runs through a dedicated careers and provider-careers funnel.

Adults, couples, and families seeking therapy for clinical conditions (anxiety, depression, ADHD, bipolar disorder, insomnia, chronic pain, eating disorders, panic, personality disorders, phobias, self-harm, substance use, trauma/PTSD) and general concerns (stress and burnout, life transitions, grief, self-esteem, cultural identity, racial trauma, LGBTQ+ support). On the supply side, Octave recruits licensed therapists as contractors or employees; it also contracts with national health insurance payers.

Geography

Headquartered in San Francisco. At the time of the June 2023 Series C, Octave operated in California, Connecticut, Florida, New Jersey, New York, Texas, and Washington, D.C., with stated plans to expand to additional regions later in 2023 and to all 50 states in 2024. Built In lists six offices, in San Francisco, Oakland, and Los Angeles, California, and New York, New York; the company states it works fully remotely with select California and New York locations available for hybrid schedules.

History

Octave launched in 2018 and grew a network of virtual and in-person clinics offering insurance-covered therapy. Cigna Ventures began collaborating with the company in 2021. In June 2023 Octave announced a $52 million Series C led by Cigna Ventures, Novo Holdings, and Avidity Partners, bringing total disclosed funding to $86 million at that time, and set out plans for nationwide expansion and new payer- and provider-facing technology.

Risks & controversies

The sources contain no reports of controversies. Notable caveats: outcome, satisfaction, cost, and volume statistics originate from Octave's own marketing materials and are not independently verified; the stated goal of reaching all 50 states in 2024 is not confirmed by any later source; and operating in-network makes revenue dependent on payer contracts and reimbursement rates. A separate San Francisco company also named Octave (an AI go-to-market marketing platform) and an unrelated venture fund at octave.fund exist, creating name-collision risk in data collection.